mutat
one
gene
caus
abnorm
cell
behavior
lead
synthesi
dysfunct
protein
mutat
inevit
result
cell
function
margin
genet
mutat
interfer
cell
normal
life
cycl
especi
celldivis
cycl
goal
behind
recombin
dna
technolog
deliv
correct
version
mutat
gene
cell
express
lead
normal
product
protein
restor
normal
cell
function
consid
qualit
differ
convent
treatment
due
genet
materi
put
therapeut
agent
alter
genet
materi
cell
gene
therapi
may
correct
one
day
cure
specif
diseas
pathophysiolog
genet
engin
use
veterinari
medicin
diagnos
prevent
treat
diseas
breed
differ
speci
produc
transgen
anim
therapeut
protein
xenograft
review
current
statu
recombin
dna
technolog
applic
veterinari
medicin
togeth
obstacl
applic
genet
engin
veterinari
medicin
discuss
therapi
includ
cell
nucleu
entri
intracellular
stabil
vector
transfect
ethic
mani
obstacl
overcom
gene
issu
difficulti
basic
level
includ
shortcom
gene
transfer
vector
inadequ
understand
biolog
interact
correspond
author
success
gene
therapi
requir
acid
deriv
limit
amount
materi
identif
appropri
therapeut
gene
asid
diagnosi
infect
pcr
also
reli
heavili
deliveri
system
util
identifi
parasit
genet
gene
deliv
effici
character
isol
character
accur
deliveri
system
must
reexpress
gene
detect
anthelmint
strict
way
leav
normal
cell
resist
pcr
sensit
unaffect
detriment
affect
bystand
singl
viru
bacterium
parasit
cell
suffici
cell
transduct
target
may
achiev
detect
provid
part
nucleic
acid
engin
surfac
compon
virus
sequenc
known
sinc
nucleic
acid
much
liposom
level
target
cell
recognit
stabl
enzym
protein
incorpor
transcript
element
materi
need
fresh
store
plasmid
viral
genom
enthusiasm
special
condit
pcr
also
tend
quicker
proceed
clinic
trial
basic
studi
diseas
immunodetect
method
stanpathophysiolog
given
adequ
attendard
carri
diagnost
tion
howev
basic
studi
essenti
sinc
laboratori
carri
appropri
anim
much
research
preform
studi
model
lead
altern
treatment
stratefelin
infecti
periton
fip
common
gie
better
understand
target
cell
subset
neurolog
diseas
fip
fatal
arthusoveral
effect
design
therapeut
aptyp
immun
respons
cat
may
occur
sysproach
studi
differ
human
temic
singl
organ
system
antemortem
diseas
anim
model
phenotyp
may
lead
indic
diseas
posit
antiinsight
diseas
pathogenesi
may
excoronaviru
igg
titer
cerebrospin
fluid
high
ploit
either
gene
therapi
pharmacolog
serum
protein
concentr
find
use
magapproach
addit
gene
lead
human
netic
reson
imag
suggest
periventricular
condiseas
isol
gene
target
transgen
trast
enhanc
ventricular
dilat
hydrotechnolog
gener
mous
model
cephalu
postmortem
diagnosi
may
detect
human
diseas
anticip
increasus
techniqu
fip
monoclon
antibodi
ingli
product
use
model
elucid
stain
affect
tissu
coronavirusdiseas
pathophysiolog
lead
effici
specif
pcr
gene
therapi
approach
viremia
felin
coronaviru
necessarili
lead
fip
death
thu
make
posit
felin
coronaviru
low
prognost
diagnost
valu
howev
util
felin
veterinari
applic
specif
pcr
may
reliabl
sampl
peripher
blood
mononuclear
cell
pbmc
diagnost
test
use
studi
pathogenesi
epidemiolog
fip
parallel
number
applic
nucleic
acid
probe
studi
dot
blot
hybrid
assay
found
dna
product
monoclon
antibodi
valu
coronaviru
infect
cat
use
clinic
diagnost
use
veterinari
medicin
biotinyl
cdna
probe
assay
abl
increas
rapidli
detect
fipv
rna
particular
cell
infect
fipv
isol
vivo
studi
probe
nucleic
acid
use
detect
fipv
rna
peripher
blood
polymeras
chain
reaction
pcr
mononuclear
leukocyt
pbml
cat
infect
major
impact
diagnost
area
veterinari
fipproduc
coronaviru
isol
medicin
broad
applic
pcr
due
revers
transcript
semiquantit
pcr
sensit
permit
enzymat
amplif
detect
chang
pbmc
cytokin
mrna
level
gene
fragment
minut
quantiti
nucleic
assess
specif
interleukin
il
interferon
ifn
studi
preform
use
two
recombiand
genet
impact
monoclon
antibodi
nant
fipv
felin
infecti
periton
viru
spike
mab
diagnost
technolog
therapeut
protein
kitten
chalregim
equal
dramat
limit
leng
fipv
kitten
deth
manner
antigenantibodi
interact
velop
sign
fip
confirm
control
use
mab
also
hinder
gross
post
mortem
examin
recombin
abil
consist
produc
antibodi
protein
induc
specif
antibodi
respons
appropri
affin
specif
fail
alter
cours
diseas
week
biotechnolog
method
continu
show
promaft
viru
challeng
pbmc
show
small
ise
improv
diagnost
prophylact
purincreas
express
ifn
gamma
pose
product
mab
direct
viral
mrna
also
notic
fip
develop
bacteriaspecif
antigen
classic
swine
mrna
level
variou
il
ifn
gamma
fever
viru
bovin
viru
diarrhea
viru
anim
becam
markedli
depress
parvovirus
felin
leukaemia
viru
alphaviru
pcr
assay
develop
detect
bovin
retrosbrucella
francisella
current
use
pumaviru
bovin
syncyti
viru
bsv
use
two
biotechnolog
techniqu
differ
set
oligonucleotid
primer
varieti
mab
highli
specif
effecprim
use
compar
abil
tive
instrument
studi
hog
cholera
viru
amplifi
target
bsv
sequenc
pcr
use
mab
studi
viral
antigen
specif
pcr
primer
set
test
structur
function
characterist
surfac
confirm
amplifi
cdna
product
protein
becam
possibl
singl
map
expect
size
react
posit
correfunct
antigen
site
surfac
glycoprotein
spond
virusspecif
cdna
probe
specif
map
function
led
detect
assay
target
specif
gene
region
relationship
rnase
activ
bsv
proviru
genom
pcr
use
structur
compon
anoth
surfac
glycoproconfirm
presenc
bsv
cell
cultur
tein
turn
envelop
glycopr
viru
isol
diagnosi
tein
immunogen
protein
classic
infect
bovin
pbl
abe
et
al
swine
fever
viru
csfv
immun
respons
found
possibl
detect
bovineiminduc
protect
pig
csfv
munodeficiencylik
viru
use
capsid
transindirect
block
elisa
complex
block
membran
envelop
protein
recombin
assay
ctb
base
two
independ
structur
baculoviru
posit
detect
presenc
antigen
unit
routin
use
worldwid
antibiv
antibodi
confirm
use
recombiserolog
diagnosi
csfv
infect
nant
protein
test
antigen
serodetect
studi
mab
measur
phenotyp
bivinfect
anim
chang
circul
leukocyt
also
imth
polymeras
chain
reaction
also
util
plement
diagnosi
indic
csfv
infor
identif
food
spoilag
microorgan
fection
pattern
phenotyp
chang
vari
pcr
along
dna
base
type
virul
csfv
infect
virul
notabl
fingerprint
method
enabl
clear
instrain
result
dramat
earli
loss
ident
microorgan
differ
bear
lymphocyt
circul
level
vari
genu
strain
level
di
studi
applic
elisa
enzymecrimin
subspeci
strain
level
link
immunosorb
assay
detect
antibodi
possibl
investig
rout
sourc
serum
sheep
dichelobact
nodosu
contamin
assist
confirm
potenti
elisa
veterinari
medicin
measur
antibodi
monoclon
antibodi
nodosu
use
elisa
possibl
applic
immunolog
techniqu
detect
recent
occurr
virul
footrot
respons
exponenti
growth
young
sheep
turn
could
util
understand
biochem
research
biochemistri
inappropri
use
vaccin
footrot
protect
area
confirm
prior
vaccin
sheep
adenovirusbas
vector
develop
asid
assess
vaccin
statu
flock
use
vector
result
clinic
test
could
prove
use
farm
relev
level
human
factor
viii
mice
virul
footrot
erad
breed
hemophil
dog
stock
confirm
freedom
activ
polymeras
chain
reaction
discuss
earlier
infect
sought
young
sheep
period
use
amplifi
entir
code
region
favor
transmiss
canin
factor
ix
hemophilia
b
anim
use
two
mab
simpl
reliabl
mutat
respons
canin
hemophilia
b
rerapid
block
elisa
ceditest
detect
bovin
sult
complet
lack
circul
factor
ix
viru
diarrhoea
viru
bvdv
specif
antibodi
affect
anim
observ
mutat
would
cattl
serum
plasma
bulk
milk
block
major
advers
effect
tertiari
structur
elisa
abl
detect
specif
antibodi
serum
aberr
factor
ix
molecul
elucid
obtain
day
acut
infect
mutat
shed
light
structurefunct
relaserum
vaccin
challeng
anim
tionship
factor
ix
facilit
futur
specif
elisa
test
preform
high
experi
direct
toward
gene
therapi
reproduc
use
undilut
sampl
diseas
similar
studi
recombin
reliabl
use
diagnosi
bvdv
infect
adenoassoci
viral
vector
raav
contain
largescal
screen
erad
program
canin
factor
ix
cdna
infus
liver
canin
model
hemophilia
b
dose
diseas
prevent
treatment
raav
administ
hemophil
dog
result
show
dog
normal
canin
factor
ix
immunolog
veterinari
medicin
vetlevel
absenc
inhibitor
sustain
erinari
vaccin
contribut
health
anim
partial
correct
coagul
defect
reduc
econom
loss
result
diseas
least
month
increas
agricultur
product
assurherzog
et
al
use
viral
gene
deliveri
anc
high
qualiti
food
custom
dna
system
seri
percutan
intramuscuvaccin
applic
veterinari
medicin
lar
inject
adenoassoci
viral
vector
explain
recent
paper
administ
singl
time
point
associathi
theme
issu
author
type
tion
local
system
toxic
five
hemophilia
diseas
consider
somat
gene
b
dog
treat
show
stabl
vector
dosetherapi
divers
mani
differ
underlydepend
partial
correct
whole
blood
ing
caus
therefor
rational
strategi
clot
time
higher
dose
activ
treat
particular
diseas
vari
partial
thromboplastin
time
mani
inherit
diseas
result
mutat
krabb
diseas
sever
disord
singl
gene
sickl
cell
anemia
hemophilia
peripher
central
nervou
system
myelin
caus
cystic
fibrosi
hypercoholesterolemia
defici
galactocerebrosidas
activ
galc
hemophilia
hemophilia
b
x
chrothi
auotosom
recess
diseas
affect
human
mosomelink
recess
bleed
disord
anim
includ
dog
mice
rhesu
monresult
defici
coagul
factor
key
baskin
et
al
describ
clinic
patholog
viii
ix
respect
dna
technolog
biochem
featur
affect
rhesu
shown
success
demonstr
partial
persist
cormonkey
affect
monkey
low
rection
canin
model
hemophilia
b
galc
activ
two
base
pair
delet
gene
therapi
hemophilia
sinc
copi
galc
gene
clinic
sign
tremor
reach
development
stage
hypertonia
incoordin
led
human
hemophilia
b
establish
reduc
euthanasia
month
age
neuroscopi
express
human
clot
factor
viii
cdna
peripher
nerv
enlarg
result
reveal
caus
transcript
regress
increas
rhesu
monkey
model
use
explorexpress
factor
viii
improv
retrovir
vector
ing
treatment
option
includ
prenat
bone
marrow
transplant
variou
approach
gene
strong
immun
respons
lead
tumor
growth
therapi
inhibit
reject
common
diseas
coronari
heart
safeti
efficaci
intratumor
inject
diseas
diabetu
typic
sever
gene
bacteri
superantigen
cytokin
gene
involv
thu
make
singl
gene
mechan
dog
malign
melanoma
evalu
except
knowledg
pathophysiolog
begindow
et
al
dog
melanoma
ning
suggest
particular
instanc
treat
lipidplasmid
dna
encod
staphylointroduct
specif
gene
might
revers
retard
coccal
enterotoxin
b
either
gmcsf
diseas
process
cellular
level
gener
result
show
surviv
time
anim
approach
may
prove
effect
regardless
genet
stage
iii
melanoma
treat
intratumor
gene
etiolog
without
need
replac
singl
therapi
prolong
significantli
compar
miss
gene
product
anim
treat
surgic
excis
alon
past
two
decad
studi
reveal
addit
local
tumor
transfect
superantigen
cancer
genet
diseas
cellular
level
cytokin
gene
capabl
induc
multistag
process
driven
inherit
somat
local
system
antitumor
immun
outmut
cellular
gene
follow
clonal
selecbre
anim
spontan
develop
maligt
variant
cell
increas
aggress
nant
tumor
growth
properti
cytokin
may
use
effect
newli
hatch
chicken
highli
suscept
administ
system
may
offer
subinfect
first
two
week
life
stantial
clinic
benefit
certain
cancer
viral
util
cytokin
therapeut
agent
infect
product
may
signific
clinilivestock
anim
particular
poultri
becom
cal
impact
highli
fatal
disord
canin
feasibl
recent
clone
cytokin
howev
product
administ
sysgen
progress
new
technolog
temic
perturb
complex
regulatori
pathway
rea
live
vector
lowenthal
et
al
construct
sult
seriou
side
effect
live
recombin
fowlpox
viru
fpv
express
melanoma
common
neoplast
diseas
dog
chicken
myelomonocyt
growth
factor
mgf
adwith
vari
present
biolog
behavior
ministr
mgf
chick
result
mark
canin
malign
melanoma
rapidli
metastat
sustain
increas
number
circul
diseas
gener
incur
standard
therablood
monocyt
well
increas
state
peutic
approach
chemotherapi
activ
measur
enhanc
phagocyt
radiotherapi
yet
proven
effect
activ
elev
product
nitric
oxid
canin
malign
melanoma
recent
genet
administr
ifn
improv
chick
resist
therapi
studi
shown
promis
reduc
diseas
challeng
mortal
dog
affect
malign
melanoma
cytokin
gene
engin
tumor
vaccin
anoth
studi
antigen
identifi
current
area
intens
investig
mab
observ
wellconserv
highli
basic
research
clinic
medicin
hogg
et
al
express
cell
surfac
protein
present
util
tumor
vaccin
immunoal
phase
cell
cycl
malign
canin
therapeut
manner
involv
canin
spontamelanoma
consist
express
suggest
neou
tumor
dog
vaccin
prithat
antigen
may
potenti
use
treat
mari
auotolog
tumor
cell
transfect
hgmdog
melanoma
found
csf
report
control
gene
exogen
protein
treat
metastat
melanoma
canin
tumor
detect
h
post
inject
dramat
surgeri
radiotherapi
repeat
local
inject
histolog
chang
observ
character
xenogen
vero
cell
relaps
less
frequent
neutrophil
macrophag
infiltr
site
surviv
longer
dog
treat
surgeri
inject
gmcsf
transfect
cell
radiotherapi
alon
xenogen
vero
cell
although
wellcharacter
observ
secret
high
level
human
primari
immun
defici
pid
food
anim
produc
local
tumor
site
promot
diseas
import
tend
sever
cure
anim
pid
et
al
determin
whether
compar
mutat
receiv
intens
aggress
care
requir
present
gene
meat
breed
sheep
surviv
therefor
veterinarian
cattl
preliminari
data
suggest
mstn
mutaawar
disord
seek
correct
diagnosi
tion
caus
loss
function
cattl
differ
mutat
may
affect
express
henc
muscular
gene
encod
cytokin
potenti
candid
diseas
resist
quantit
trait
long
time
human
be
breed
loci
cattl
rel
member
gene
anim
increas
strength
feed
effici
famili
posit
bovin
genet
diseas
resist
recent
advanc
molecular
map
inform
marker
associ
cytokin
biolog
creat
belief
anim
breed
gene
may
incorpor
genom
wide
qtl
revolution
futur
quantit
trait
scan
resourc
cattl
popul
defin
locu
approach
qtl
type
dna
marker
level
herit
resist
parasit
nematod
segreg
popul
success
infect
identifi
mani
chromosom
region
involv
growth
bodi
composit
transgen
anim
tion
anim
potenti
qtl
influenc
trait
fat
thick
retail
product
yield
ovul
except
process
produc
rate
meat
tender
dairi
form
transgen
anim
straightforward
identifi
beef
cattl
therefor
use
new
variou
manipul
perform
mani
genom
tool
studi
gene
express
chang
still
fairli
earli
stage
develop
prove
power
dissect
select
rehuman
growth
hormon
introduc
mice
spons
underli
compon
qtl
pig
earli
experi
mani
problem
quantit
trait
loci
qtl
affect
milk
protein
found
thu
halt
futur
studi
far
largest
percent
map
israel
holstein
dairi
produc
transgen
mice
heard
use
select
dna
pool
sampl
date
model
human
diseas
suffici
simibas
compris
milk
sampl
collect
lariti
human
mous
gene
daughter
seven
sire
second
stage
human
gene
identifi
equival
gene
milk
sampl
collect
daughter
mous
disabl
observ
similar
effect
siren
daughter
compris
high
altern
oncomous
produc
low
phenotyp
extrem
protein
percent
contain
genet
defect
caus
controversi
milk
yield
protein
yield
seven
marker
six
mous
becam
subject
patent
chromosom
show
signific
effect
protein
applic
gener
less
controversi
approach
yield
marker
nine
chromosom
show
novel
idea
genet
engin
signific
effect
milk
yield
mammal
produc
protein
milk
serv
anoth
studi
rapacz
et
al
show
potenti
medic
benefit
pharmaceut
agent
effect
barley
even
primros
lead
exampl
area
shown
lower
cholesterol
egg
yolk
also
variat
tabl
profil
fatti
acid
yolk
hen
anoth
potenti
use
genet
engin
deriv
two
commerci
cross
white
shell
tissu
organ
transplant
xenograft
offer
egg
brown
shell
egg
result
reveal
potenti
use
anim
organ
transplant
use
genet
marker
associ
environhuman
heart
kidney
scientist
hope
ment
could
use
tool
product
genet
engin
anim
human
egg
human
consumpt
desir
gene
produc
therapeut
protein
send
content
fatti
acid
cholesterol
loss
correct
signal
human
howev
function
mutat
myostatin
gene
mstn
mani
problem
need
address
includ
produc
muscl
hyperplasia
cattl
term
muscureject
transplant
tissu
moreov
point
lar
hypertrophi
mous
compact
lord
time
earlier
dolli
announc
